We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Monash IVF Group is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Monash IVF Group has a trailing 12-month revenue of around $193.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
| 52-week range | $0.7701 - $1.265 |
|---|---|
| 50-day moving average | $1.1172 |
| 200-day moving average | $1.0457 |
| Target price | $0.9 |
| PE ratio | 16.1207 |
| Dividend yield | $0.043 (4.66%) |
| Earnings per share (TTM) | $0.058 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.955
| 1 week (2022-06-17) | 3.80% |
|---|---|
| 1 month (2022-05-25) | -10.33% |
| 3 months (2022-03-25) | -21.40% |
| 6 months (2021-12-24) | -10.33% |
| 1 year (2021-06-25) | 12.35% |
|---|---|
| 2 years (2020-06-25) | 73.64% |
| 3 years (2019-06-25) | -33.91% |
| 5 years (2017-06-23) | -45.74% |
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Monash IVF Group shares trade at around 16x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $39 million (£0.0 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $193.8 million |
|---|---|
| Operating margin TTM | 17.3% |
| Gross profit TTM | $66.4 million |
| Return on assets TTM | 6.06% |
| Return on equity TTM | 8.49% |
| Profit margin | 11.65% |
| Book value | 0.694 |
| Market capitalisation | $364.3 million |
TTM: trailing 12 months
Dividend payout ratio: 71.67% of net profits
Recently Monash IVF Group has paid out, on average, around 71.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 4.66% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.043 per share.
Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 March 2022 (the "ex-dividend date").
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.7701 up to $1.265. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.6787. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
